BRCA1 Can Modulate RNA Polymerase II Carboxy-Terminal Domain Phosphorylation Levels

REFERENCES

• Abbott, D. W., Thompson M. E., Robinson-Benion C., Tomlinson G., Jensen R. A., and Holt J. T.. 1999. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J. Biol. Chem. 274:18808–18812.
   PubMed Web of Science ®Google Scholar
• Akoulitchev, S., Makela T. P., Weinberg R. A., and Reinberg D.. 1995. Requirement for TFIIH kinase activity in transcription by RNA polymerase II. Nature 377:557–560.
   PubMedGoogle Scholar
• Akoulitchev, S., and Reinberg D.. 1998. The molecular mechanism of mitotic inhibition of TFIIH is mediated by phosphorylation of CDK7. Genes Dev. 12:3541–3550.
   PubMed Web of Science ®Google Scholar
• Anderson, S. F., Schlegel B. P., Nakajima T., Wolpin E. S., and Parvin J. D.. 1998. BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat. Genet. 19:254–256.
   PubMed Web of Science ®Google Scholar
• Aprelikova, O., Pace A. J., Fang B., Koller B. H., and Liu E. T.. 2001. BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J. Biol. Chem. 276:25647–25650.
   PubMedGoogle Scholar
• Araujo, S. J., Tirode F., Coin F., Pospiech H., Syvaoja J. E., Stucki M., Hubscher U., Egly J. M., and Wood R. D.. 2000. Nucleotide excision repair of DNA with recombinant human proteins: definition of the minimal set of factors, active forms of TFIIH, and modulation by CAK. Genes Dev. 14:349–359.
   PubMed Web of Science ®Google Scholar
• Blau, J., Xiao H., McCracken S., O'Hare P., Greenblatt J., and Bentley D.. 1996. Three functional classes of transcriptional activation domain. Mol. Cell. Biol. 16:2044–2055.
   PubMed Web of Science ®Google Scholar
• Bregman, D. B., Halaban R., van Gool A. J., Henning K. A., Friedberg E. C., and Warren S. L.. 1996. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proc. Natl. Acad. Sci. USA 93:11586–11590.
   PubMed Web of Science ®Google Scholar
• Busso, D., Keriel A., Sandrock B., Poterszman A., Gileadi O., and Egly J. M.. 2000. Distinct regions of MAT1 regulate cdk7 kinase and TFIIH transcription activities. J. Biol. Chem. 275:22815–22823.
   PubMedGoogle Scholar
• Carey, M., Lin Y. S., Green M. R., and Ptashne M.. 1990. A mechanism for synergistic activation of a mammalian gene by GAL4 derivatives. Nature 345:361–364.
   PubMedGoogle Scholar
• Carvalho, M. A., Billack B., Chan E., Worley T., Cayanan C., and Monteiro A. N.. 2002. Mutations in the BRCT domain confer temperature sensitivity to BRCA1 in transcription activation. Cancer Biol. Ther. 1:502–508.
   PubMed Web of Science ®Google Scholar
• Chapman, M. S., and Verma I. M.. 1996. Transcriptional activation by BRCA1. Nature 382:678–679.
   PubMedGoogle Scholar
• Chapman, R. D., Palancade B., Lang A., Bensaude O., and Eick D.. 2004. The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability. Nucleic Acids Res. 32:35–44.
   PubMed Web of Science ®Google Scholar
• Coin, F., and Egly J. M.. 1998. Ten years of TFIIH. Cold Spring Harbor Symp. Quant. Biol. 63:105–110.
   PubMedGoogle Scholar
• Dahmus, M. E. 1996. Phosphorylation of mammalian RNA polymerase II. Methods Enzymol. 273:185–193.
   PubMedGoogle Scholar
• Deng, C. X., and Brodie S. G.. 2000. Roles of BRCA1 and its interacting proteins. Bioessays 22:728–737.
   PubMed Web of Science ®Google Scholar
• Dvir, A., Conaway J. W., and Conaway R. C.. 2001. Mechanism of transcription initiation and promoter escape by RNA polymerase II. Curr. Opin. Genet. Dev. 11:209–214.
   PubMedGoogle Scholar
• Feaver, W. J., Svejstrup J. Q., Henry N. L., and Kornberg R. D.. 1994. Relationship of CDK-activating kinase and RNA polymerase II CTD kinase TFIIH/TFIIK. Cell 79:1103–1109.
   PubMed Web of Science ®Google Scholar
• Fisher, R. P., Jin P., Chamberlin H. M., and Morgan D. O.. 1995. Alternative mechanisms of CAK assembly require an assembly factor or an activating kinase. Cell 83:47–57.
   PubMedGoogle Scholar
• Fong, N., Bird G., Vigneron M., and Bentley D. L.. 2003. A 10 residue motif at the C-terminus of the RNA pol II CTD is required for transcription, splicing and 3′ end processing. EMBO J. 22:4274–4282.
   PubMed Web of Science ®Google Scholar
• Garrett, M. D., and Fattaey A.. 1999. CDK inhibition and cancer therapy. Curr. Opin. Genet. Dev. 9:104–111.
   PubMed Web of Science ®Google Scholar
• Garrett, S., Barton W. A., Knights R., Jin P., Morgan D. O., and Fisher R. P.. 2001. Reciprocal activation by cyclin-dependent kinases 2 and 7 is directed by substrate specificity determinants outside the T loop. Mol. Cell. Biol. 21:88–99.
   PubMed Web of Science ®Google Scholar
• Haile, D. T., and Parvin J. D.. 1999. Activation of transcription in vitro by the BRCA1 carboxyl-terminal domain. J. Biol. Chem. 274:2113–2117.
   PubMed Web of Science ®Google Scholar
• Harkin, D. P., Bean J. M., Miklos D., Song Y. H., Truong V. B., Englert C., Christians F. C., Ellisen L. W., Maheswaran S., Oliner J. D., and Haber D. A.. 1999. Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell 97:575–586.
   PubMed Web of Science ®Google Scholar
• Hartman, A. R., and Ford J. M.. 2003. BRCA1 and p53: compensatory roles in DNA repair. J. Mol. Med.
   Google Scholar
• Hartman, A. R., and Ford J. M.. 2002. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Nat. Genet. 32:180–184.
   PubMed Web of Science ®Google Scholar
• Horton, H. R., Moran L. A., Ochs R. S., Rawn J. D., and Scrimgeour K. G.. 1994. (ed.) Principes de biochimie. DeBoeck Université ed., Brussels, Belgium.
   Google Scholar
• Hu, Y. F., Hao Z. L., and Li R.. 1999. Chromatin remodeling and activation of chromosomal DNA replication by an acidic transcriptional activation domain from BRCA1. Genes Dev. 13:637–642.
   PubMed Web of Science ®Google Scholar
• Inamoto, S., Segil N., Pan Z. Q., Kimura M., and Roeder R. G.. 1997. The cyclin-dependent kinase-activating kinase (CAK) assembly factor, MAT1, targets and enhances CAK activity on the POU domains of octamer transcription factors. J. Biol. Chem. 272:29852–29858.
   PubMedGoogle Scholar
• Ko, L. J., Shieh S. Y., Chen X., Jayaraman L., Tamai K., Taya Y., Prives C., and Pan Z. Q.. 1997. p53 is phosphorylated by CDK7-cyclin H in a p36MAT1-dependent manner. Mol. Cell. Biol. 17:7220–7229.
   PubMed Web of Science ®Google Scholar
• Komarnitsky, P., Cho E. J., and Buratowski S.. 2000. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev. 14:2452–2460.
   PubMed Web of Science ®Google Scholar
• Krum, S. A., Miranda G. A., Lin C., and Lane T. F.. 2003. BRCA1 associates with processive RNA polymerase II. J. Biol. Chem. 278:52012–52020.
   PubMed Web of Science ®Google Scholar
• Larochelle, S., Chen J., Knights R., Pandur J., Morcillo P., Erdjument-Bromage H., Tempst P., Suter B., and Fisher R. P.. 2001. T-loop phosphorylation stabilizes the CDK7-cyclin H-MAT1 complex in vivo and regulates its CTD kinase activity. EMBO J. 20:3749–3759.
   PubMed Web of Science ®Google Scholar
• Lee, T. I., and Young R. A.. 2000. Transcription of eukaryotic protein-coding genes. Annu. Rev. Genet. 34:77–137.
   PubMed Web of Science ®Google Scholar
• MacLachlan, T. K., Somasundaram K., Sgagias M., Shifman Y., Muschel R. J., Cowan K. H., and El-Deiry W. S.. 2000. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J. Biol. Chem. 275:2777–2785.
   PubMedGoogle Scholar
• Mallouk, Y., Vayssier-Taussat M., Bonventre J. V., and Polla B. S.. 1999. Heat shock protein 70 and ATP as partners in cell homeostasis. Int. J. Mol. Med. 4:463–474.
   PubMed Web of Science ®Google Scholar
• Manke, I. A., Lowery D. M., Nguyen A., and Yaffe M. B.. 2003. BRCT repeats as phosphopeptide-binding modules involved in protein targeting. Science 302:636–639.
   PubMed Web of Science ®Google Scholar
• Marshall, N. F., and Price D. H.. 1995. Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270:12335–12338.
   PubMed Web of Science ®Google Scholar
• Monteiro, A. N. 2002. Participation of BRCA1 in the DNA repair response via transcription. Cancer Biol. Ther. 1:187–188.
   PubMed Web of Science ®Google Scholar
• Monteiro, A. N., August A., and Hanafusa H.. 1996. Evidence for a transcriptional activation function of BRCA1 C-terminal region. Proc. Natl. Acad. Sci. USA 93:13595–13599.
   PubMed Web of Science ®Google Scholar
• Nadeau, G., Boufaied N., Moisan A., Lemieux K. M., Cayanan C., Monteiro A. N., and Gaudreau L.. 2000. BRCA1 can stimulate gene transcription by a unique mechanism. EMBO Rep. 1:260–265.
   PubMedGoogle Scholar
• O'Brien, K. A., Lemke S. J., Cocke K. S., Rao R. N., and Beckmann R. P.. 1999. Casein kinase 2 binds to and phosphorylates BRCA1. Biochem. Biophys. Res. Commun. 260:658–664.
   PubMedGoogle Scholar
• Oelgeschlager, T. 2002. Regulation of RNA polymerase II activity by CTD phosphorylation and cell cycle control. J. Cell Physiol. 190:160–169.
   PubMed Web of Science ®Google Scholar
• Ohkuma, Y., Hashimoto S., Wang C. K., Horikoshi M., and Roeder R. G.. 1995. Analysis of the role of TFIIE in basal transcription and TFIIH-mediated carboxy-terminal domain phosphorylation through structure-function studies of TFIIE-α. Mol. Cell. Biol. 15:4856–4866.
   PubMedGoogle Scholar
• Okamoto, T., Yamamoto S., Watanabe Y., Ohta T., Hanaoka F., Roeder R. G., and Ohkuma Y.. 1998. Analysis of the role of TFIIE in transcriptional regulation through structure-function studies of the TFIIEbeta subunit. J. Biol. Chem. 273:19866–19876.
   PubMedGoogle Scholar
• Paull, T. T., Cortez D., Bowers B., Elledge S. J., and Gellert M.. 2001. Direct DNA binding by Brca1. Proc. Natl. Acad. Sci. USA 98:6086–6091.
   PubMed Web of Science ®Google Scholar
• Ptashne, M., and Gann A.. 1997. Transcriptional activation by recruitment. Nature 386:569–577.
   PubMed Web of Science ®Google Scholar
• Ratner, J. N., Balasubramanian B., Corden J., Warren S. L., and Bregman D. B.. 1998. Ultraviolet radiation-induced ubiquitination and proteasomal degradation of the large subunit of RNA polymerase II. Implications for transcription-coupled DNA repair. J. Biol. Chem. 273:5184–5189.
   PubMed Web of Science ®Google Scholar
• Rickert, P., Corden J. L., and Lees E.. 1999. Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases. Oncogene 18:1093–1102.
   PubMed Web of Science ®Google Scholar
• Rossignol, M., Kolb-Cheynel I., and Egly J. M.. 1997. Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH. EMBO J. 16:1628–1637.
   PubMedGoogle Scholar
• Scully, R., Anderson S. F., Chao D. M., Wei W., Ye L., Young R. A., Livingston D. M., and Parvin J. D.. 1997. BRCA1 is a component of the RNA polymerase II holoenzyme. Proc. Natl. Acad. Sci. USA 94:5605–5610.
   PubMed Web of Science ®Google Scholar
• Solomon, M. J., Harper J. W., and Shuttleworth J.. 1993. CAK, the p34cdc2 activating kinase, contains a protein identical or closely related to p40MO15. EMBO J. 12:3133–3142.
   PubMed Web of Science ®Google Scholar
• Somasundaram, K. 2003. Breast cancer gene 1 (BRCA1): role in cell cycle regulation and DNA repair—perhaps through transcription. J. Cell Biochem. 88:1084–1091.
   PubMedGoogle Scholar
• Somasundaram, K., Zhang H., Zeng Y. X., Houvras Y., Peng Y., Wu G. S., Licht J. D., Weber B. L., and El-Deiry W. S.. 1997. Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1. Nature 389:187–190.
   PubMed Web of Science ®Google Scholar
• Sun, X., Zhang Y., Cho H., Rickert P., Lees E., Lane W., and Reinberg D.. 1998. NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol. Cell 2:213–222.
   PubMed Web of Science ®Google Scholar
• Talukder, A. H., Mishra S. K., Mandal M., Balasenthil S., Mehta S., Sahin A. A., Barnes C. J., and Kumar R.. 2003. MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions. J. Biol. Chem. 278:11676–11685.
   PubMedGoogle Scholar
• Wallenfang, M. R., and Seydoux G.. 2002. cdk-7 is required for mRNA transcription and cell cycle progression in Caenorhabditis elegans embryos. Proc. Natl. Acad. Sci. USA 99:5527–5532.
   PubMedGoogle Scholar
• Welcsh, P. L., Lee M. K., Gonzalez-Hernandez R. M., Black D. J., Mahadevappa M., Swisher E. M., Warrington J. A., and King M. C.. 2002. BRCA1 transcriptionally regulates genes involved in breast tumorigenesis. Proc. Natl. Acad. Sci. USA 99:7560–7565.
   PubMed Web of Science ®Google Scholar
• Whitmarsh, A. J., and Davis R. J.. 2001. Analyzing JNK and p38 mitogen-activated protein kinase activity. Methods Enzymol. 332:319–336.
   PubMedGoogle Scholar
• Williams, R. S., Chasman D., Hau D., Hui B., Lau A., and Glover J. N.. 2003. Detection of protein folding defects caused by BRCA1-BRCT truncation and missense mutations. J. Biol. Chem. 278:53007–53016.
   PubMedGoogle Scholar
• Williams, R. S., Green R., and Glover J. N.. 2001. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1. Nat. Struct. Biol. 8:838–842.
   PubMedGoogle Scholar
• Williamson, E. A., Dadmanesh F., and Koeffler H. P.. 2002. BRCA1 transactivates the cyclin-dependent kinase inhibitor p27(Kip1). Oncogene 21:3199–3206.
   PubMedGoogle Scholar
• Xu, X., Nakano T., Wick S., Dubay M., and Brizuela L.. 1999. Mechanism of Cdk2/Cyclin E inhibition by p27 and p27 phosphorylation. Biochemistry 38:8713–8722.
   PubMedGoogle Scholar
• Yamane, K., and Tsuruo T.. 1999. Conserved BRCT regions of TopBP1 and of the tumor suppressor BRCA1 bind strand breaks and termini of DNA. Oncogene 18:5194–5203.
   PubMedGoogle Scholar
• Yankulov, K. Y., and Bentley D. L.. 1997. Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J. 16:1638–1646.
   PubMedGoogle Scholar
• Yu, X., Chini C. C., He M., Mer G., and Chen J.. 2003. The BRCT domain is a phospho-protein binding domain. Science 302:639–642.
   PubMed Web of Science ®Google Scholar
• Yudkovsky, N., Ranish J. A., and Hahn S.. 2000. A transcription reinitiation intermediate that is stabilized by activator. Nature 408:225–229.
   PubMed Web of Science ®Google Scholar
• Zawel, L., Lu H., Cisek L. J., Corden J. L., and Reinberg D.. 1993. The cycling of RNA polymerase II during transcription. Cold Spring Harbor Symp. Quant. Biol. 58:187–198.
   PubMedGoogle Scholar
• Zhang, J., and Corden J. L.. 1991. Phosphorylation causes a conformational change in the carboxyl-terminal domain of the mouse RNA polymerase II largest subunit. J. Biol. Chem. 266:2297–2302.
   PubMedGoogle Scholar